Dicerna Pharmaceuticals
Dicerna Pharmaceuticals Inc (Form: DEFA14A, Received: 04/29/2016 14:28:47)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. 1)

 

 

Filed by the Registrant   x                              Filed by a Party other than the Registrant   ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material Pursuant to §240.14a-12

Dicerna Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

 

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 14, 2016

 

     

 

LOGO

LOGO   

 

 

 

DICERNA PHARMACEUTICALS, INC.

 

 

LOGO

 

          Meeting Information  
       

 

 Meeting Type:  Annual Meeting

       
       

 

 For holders as of: April 19, 2016

       
       

 

 Date:  June 14, 2016             Time: 9:00 AM EST

 
       

 

  Location:

 

 

 The Ocean House

 1 Bluff Avenue

 Watch Hill, RI 02891

       
                       
                     
       

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 
       

See the reverse side of this notice to obtain proxy materials  and voting instructions.

 
         

 

LOGO


  Before You Vote  

How to Access the Proxy Materials

 

    

Proxy Materials Available to VIEW or RECEIVE:

 

     
    

1. Notice & Proxy Statement         2. Form 10-K

 

     
    

How to View Online:

Have the information that is printed in the box marked by the arrow    LOGO    (located on the following page) and visit: www.proxyvote.com.

     
    

 

How to Request and Receive a PAPER or E-MAIL Copy:

     
    

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

     
    

1)  BY INTERNET :

 

www.proxyvote.com

     
    

2)  BY TELEPHONE :

 

1-800-579-1639

     
    

3) BY E-MAIL *:

 

sendmaterial@proxyvote.com

     
    

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow    LOGO    (located on the following page) in the subject line.

     
    

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 31, 2016 to facilitate timely delivery.

 

     
        
    

  How To Vote  

Please Choose One of the Following Voting Methods

 

   
            

LOGO       

    

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow    LOGO    available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

      LOGO
        


  Voting items         LOGO
 

 

The Board of Directors recommends you

vote FOR the following:

  
 

 

1.     Election of Directors

  
 

        Nominees

  
 

1a    Douglas M. Fambrough

 

  
 

1b    Brian K. Halak

 

  
 

1c    Stephen J. Hoffman

 

  
 

1d    Peter Kolchinsky

 

  
 

1e    Dennis H. Langer

 

  
 

1f     David M. Madden

 

  
 

1g    Bruce Peacock

 

  
 

The Board of Directors recommends you

vote FOR the following proposal:

  

LOGO  

 

 

 

2      To ratify the selection of Deloitte &

       Touche LLP as our independent registered

       public accounting firm for the fiscal

       year ending December 31, 2016

  
    
 

NOTE: Such other business as may properly

come before the meeting or any adjournment

thereof.

 

  
  LOGO        LOGO       


   Reserved for Broadridge Internal Control Information                                                               
                  
                  
                  
                    

 

 

NAME       

THE COMPANY NAME INC. - COMMON

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS A

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS B

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS C

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS D

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS E

     123,456,789,012.12345               

THE COMPANY NAME INC. - CLASS F

     123,456,789,012.12345               

THE COMPANY NAME INC. - 401 K

     123,456,789,012.12345               
 

 

  
             
LOGO   
             

 

Broadridge Internal Use Only

 

Job #

Envelope #

Sequence #

# of # Sequence #

  

 

THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE